好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | H197 - Navigating Medicolegal Aspects of Artificial Intelligence in Neurology (Practice and Policy Hub)

Wednesday 04/09/25
08:00 AM - 09:00 AM PDT Add To Calendar
San Diego Convention Center | 20D Lobby
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Practice and Policy)
Benjamin R. Kummer, MD, David A. Evans, MBA
Practice, Policy, and Ethics
As artificial intelligence (AI) continues to transform health care, its application in neurology presents both opportunities and risks. This course will provide a comprehensive examination of the medicolegal implications of implementing artificial intelligence in clinical practice, specifically within neurology. Participants will explore the legal, ethical, and regulatory frameworks surrounding artificial intelligence systems, focusing on how to mitigate potential risks, ensure patient safety, and comply with relevant laws and standards. The course will cover topics such as liability issues, data privacy, informed consent, intellectual property, and the role of the neurologist in AI-driven decision-making. By understanding these critical aspects, neurologists, administrators, and health care providers will be better equipped to incorporate artificial intelligence into their practice responsibly and effectively.
1.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Artificial Intelligence, Quality and Safety
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator, Coordinator
Didactic, Audience Participation

Program Materials

Event Timeline
08:00 AM - 09:00 AM PDT Speaker Navigating Medicolegal Aspects of AI in Neurology
Benjamin R. Kummer, MD, David A. Evans, MBA
Faculty Disclosures
Benjamin R. Kummer, MD Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AlphaSights. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for Gehrson Lehrman Group . Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syapse. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuraHealth. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for RONIN. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Yoeli Gottlieb Etra LLP. Dr. Kummer has stock in Syntrillo. The institution of Dr. Kummer has received research support from Icahn School of Medicine at Mount Sinai. Dr. Kummer has a non-compensated relationship as a Vice Chair Telehealth Subcommitte with 好色先生 that is relevant to AAN interests or activities. Dr. Kummer has a non-compensated relationship as a Member, Quality Informatics Subcommittee with 好色先生 that is relevant to AAN interests or activities.
David A. Evans, MBA Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI.